Age-Related Macular Degeneration, Choroidal Neovascularization, Diabetic Macular Edema, Diabetic Retinopathy, Myopic Choroidal Neovascularisation
Conditions
Brief summary
During pandemic of corona virus, patients compliance may be affected. We aim to study the factors lead to unregulated visits and its implications on the final visual outcome.
Detailed description
The corona virus pandemic may affects patients regular visits to ophthalmic clinic, we aim to study the sequel of the pandemic on intravitreal injections results in diabetic macular edema, wet age related macular degenerations, myopic choroidal new vascularization, and proliferative diabetic retinopathy.
Interventions
DRUGAnti-vascular endothelial growth factors (Anti-VEGFs)
Intravitreal injection of anti-vascular endothelial growth factors (Anti-VEGFs).
Sponsors
Benha University
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* patients with the following conditions (diabetic macular edema, wet age related macular degeneration, myopic choroidal new vascularization and retinal vein occlusion complicated with macular edema).
Exclusion criteria
* patients that are known to have hypersensitivity to Anti-VEGFs.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual acuity | Baseline and monthly after injection till one year of follow-up | Assessing the changes in best corrected visual acuity in logMAR unit measured by snellen chart. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Central subfield thickness | Baseline and monthly after injection till one year of follow-up | Assessing the changes in central macular thickness in microns measured by optical coherence tomography |
Countries
Egypt
Contacts
Primary ContactAhmed A Tabl, MD
Outcome results
None listed